Β-Phenylmethamphetamine

From WikiMD's WELLNESSPEDIA

Β-Phenylmethamphetamine‏‎ is a psychoactive drug and research chemical of the phenethylamine and amphetamine classes. It acts as a potent and selective dopamine reuptake inhibitor (DRI), but unlike methamphetamine, it does not induce the release of dopamine. The compound is often used in scientific research, particularly in the field of neuroscience.

Chemistry[edit]

Β-Phenylmethamphetamine‏‎ is a substituted amphetamine that contains a phenyl ring bound to an amino (NH2) group through a methyl chain. It is structurally similar to other amphetamines such as methamphetamine, MDMA, and amphetamine itself.

Pharmacology[edit]

As a dopamine reuptake inhibitor, Β-Phenylmethamphetamine‏‎ works by blocking the action of the dopamine transporter (DAT). This leads to increased concentrations of dopamine in the synaptic cleft, which can result in increased dopaminergic signaling. Unlike other amphetamines, Β-Phenylmethamphetamine‏‎ does not induce the release of dopamine.

Effects[edit]

The effects of Β-Phenylmethamphetamine‏‎ in humans are not well-studied. However, due to its mechanism of action, it is likely to produce effects similar to other dopamine reuptake inhibitors, such as increased alertness, euphoria, and potential for addiction.

Legal Status[edit]

The legal status of Β-Phenylmethamphetamine‏‎ varies by country. In many jurisdictions, it is considered a controlled substance due to its structural similarity to other amphetamines.

See Also[edit]




This article is a stub related to chemistry. You can help WikiMD by expanding it!


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.